High risk (B3) breast lesions: What is the incidence of malignancy for individual lesion subtypes? A systematic review and meta-analysis.

[1]  E. Morris,et al.  First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions) , 2016, Breast Cancer Research and Treatment.

[2]  Donald L Weaver,et al.  Variability in Pathologists' Interpretations of Individual Breast Biopsy Slides: A Population Perspective , 2016, Annals of Internal Medicine.

[3]  M. Aerts,et al.  Metaprop: a Stata command to perform meta-analysis of binomial data , 2014, Archives of Public Health.

[4]  H. Khalil,et al.  High-risk lesions at MRI-guided breast biopsy: frequency and rate of underestimation. , 2014, AJR. American journal of roentgenology.

[5]  D. Miglioretti,et al.  Accuracy of screening mammography in women with a history of lobular carcinoma in situ or atypical hyperplasia of the breast , 2014, Breast Cancer Research and Treatment.

[6]  D. Tiezzi,et al.  Evolving concepts in breast lobular neoplasia and invasive lobular carcinoma, and their impact on imaging methods , 2014, Insights into Imaging.

[7]  I. Amendoeira,et al.  Improved malignancy prediction by B3 breast lesions subclassification. , 2013, Annals of diagnostic pathology.

[8]  G. Maclean,et al.  Is Mode of Presentation of B3 Breast Core Biopsies (Screen-Detected or Symptomatic) a Distinguishing Factor in the Final Histopathologic Result or Risk of Diagnosis of Malignancy? , 2013, World Journal of Surgery.

[9]  R. Marcos,et al.  The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies. , 2013 .

[10]  J. M. Pearson,et al.  Benign papilloma diagnosed on image-guided 14 G core biopsy of the breast: effect of lesion type on likelihood of malignancy at excision. , 2013, Clinical radiology.

[11]  N. Sharma,et al.  New patient pathway using vacuum-assisted biopsy reduces diagnostic surgery for B3 lesions. , 2012, Clinical radiology.

[12]  J. Youk,et al.  US-Guided Vacuum-Assisted Percutaneous Excision for Management of Benign Papilloma Without Atypia Diagnosed at US-Guided 14-Gauge Core Needle Biopsy , 2012, Annals of Surgical Oncology.

[13]  I. Ellis,et al.  Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening , 2011, International journal of cancer.

[14]  A. Ancona,et al.  Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-institutional study in Italy. , 2011, Breast.

[15]  Ying-Hua Yu,et al.  Diagnostic value of vacuum-assisted breast biopsy for breast carcinoma: a meta-analysis and systematic review , 2010, Breast Cancer Research and Treatment.

[16]  Baljit Singh,et al.  Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy?: a report of 38 cases and review of the literature. , 2009, Archives of pathology & laboratory medicine.

[17]  J. Rosenberg,et al.  False-negative diagnoses at stereotactic vacuum-assisted needle breast biopsy: long-term follow-up of 1,280 lesions and review of the literature. , 2009, AJR. American journal of roentgenology.

[18]  D. Ravichandran,et al.  Screen-detected breast lesions with an indeterminate (B3) core needle biopsy should be excised. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[19]  I. Ellis,et al.  Vacuum-assisted excision of breast lesions of uncertain malignant potential (B3) - an alternative to surgery in selected cases. , 2008, Breast.

[20]  I. Ellis,et al.  Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening , 2008, Histopathology.

[21]  E. Mendelson,et al.  Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary , 2008, Modern Pathology.

[22]  P. Carder,et al.  Large volume “mammotome” biopsy may reduce the need for diagnostic surgery in papillary lesions of the breast , 2008, Journal of Clinical Pathology.

[23]  S. Ciatto,et al.  Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3) , 2007, British Journal of Cancer.

[24]  S. Ganau,et al.  Breast core biopsy reporting categories--An internal validation in a series of 3054 consecutive lesions. , 2007, Breast.

[25]  R. Brem,et al.  Percutaneous biopsy of papillary lesions of the breast: Accuracy of pathologic diagnosis , 2005 .

[26]  I. Haigh,et al.  Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast , 2005, Histopathology.

[27]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[28]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[29]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[30]  F. Burbank.  Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions: improved accuracy with directional, vacuum-assisted biopsy. , 1997, Radiology.

[31]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[32]  W. Cheng,et al.  Nonmalignant Breast Papillary Lesions at Core-Needle Biopsy: A Meta-analysis of Underestimation and Influencing Factors , 2012, Annals of Surgical Oncology.

[33]  R. J. Brenner.  Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary , 2009 .